With over 22 years of clinical drug development experience working in the contract research organization (CRO) and academic settings, David has directly managed over 30 phase I through III clinical trials worldwide from research through drug approval.

He is CEO and Principal Consultant of Telos Clinical Research LLC, an oncology trial management and consulting organization focused on Phase I and II clinical trials in the US and Europe which specializes in complex dose-escalation and dose-expansion studies of novel agents in cancer patients.